Trending...
- OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
- Men Moving Mountains Expands Full-Service Moving Options in Boone, NC and the High Country
- Crossroads4Hope Launches Blood Cancer Resource Hub
RALEIGH, N.C.--(BUSINESS WIRE)--CoSoSys, a leader in multi-OS Data Loss Prevention (DLP) solutions, announced today that it will support the upcoming macOS Ventura release, and the second generation of M-Series chips. The announcement follows updates revealed at Apple's Worldwide Developers Conference 2022 (WWDC22), and will allow CoSoSys customers to benefit from the latest Apple innovations.
As the most trusted DLP and Device Control solution for macOS in the enterprise, Endpoint Protector's same-day support for the latest releases ensures customers benefit from a stable experience and no gaps in protection.
More on ncarol.com
"More and more enterprises are taking advantage of macOS, and our continued support for the latest releases, including macOS Ventura, ensures they can immediately benefit from Apple's powerful technology and latest innovations without putting their sensitive data at risk," Roman Foeckl, CEO and founder said.
macOS Ventura, previewed during the WWDC 2022 Keynote, brings powerful productivity tools, new continuity features, and improved security. The update also includes a new Accessory Security feature for external USB and Thunderbolt accessories. The feature will require user approval before an accessory can communicate with macOS through the USB-C port, highlighting the importance of controlling removable devices and ensuring protection against USB threats. Endpoint Protector's proven Device Control feature will add to this new layer of protection, enabling a further layer of management over devices that have been approved to connect.
"Our DLP and Device Control solutions have become more important than ever before," adds Foeckl. "Enterprises are demanding greater control over the devices that employees connect to their endpoints as a way to combat data loss, and USB threats. Endpoint Protector is the only enterprise DLP solution with Device Control capabilities that achieves this level of granular management within macOS and multi-OS environments."
More on ncarol.com
About CoSoSys
Built to protect organizations from insider threats, accidental loss, and data compliance breaches, Endpoint Protector combines the visibility needed to identify at-risk data on the endpoint with the controls to stop data loss in its tracks. With support for macOS, Windows, and Linux, Endpoint Protector is proven in the enterprise and trusted across regulated industries that want to reduce the risk of a data compliance breach, or data loss from malicious, negligent, and compromised users, and demand continuous protection wherever their employees are working, even when they're offline, without impacting productivity.
Contacts
Codina Sabau, Ph.D
codina.sabau@cososys.com
www.endpointprotector.com
As the most trusted DLP and Device Control solution for macOS in the enterprise, Endpoint Protector's same-day support for the latest releases ensures customers benefit from a stable experience and no gaps in protection.
More on ncarol.com
- Postmortem Pathology Highlights Private Autopsy Options for Las Vegas Families During Summer Months
- Postmortem Pathology Offers Sacramento Families Independent Answers on a Short Timeline
- AI Is Forcing the Music Industry to Verify Who's Behind the Music. KayeDinero Has Multiple Lanes
- NEW Three Fully Furnished Single-Family Model Homes at Heritage at South Brunswick
- After 35 Years, Christian Radio Host Marina Maria Publishes the Novel She Never Forgot
"More and more enterprises are taking advantage of macOS, and our continued support for the latest releases, including macOS Ventura, ensures they can immediately benefit from Apple's powerful technology and latest innovations without putting their sensitive data at risk," Roman Foeckl, CEO and founder said.
macOS Ventura, previewed during the WWDC 2022 Keynote, brings powerful productivity tools, new continuity features, and improved security. The update also includes a new Accessory Security feature for external USB and Thunderbolt accessories. The feature will require user approval before an accessory can communicate with macOS through the USB-C port, highlighting the importance of controlling removable devices and ensuring protection against USB threats. Endpoint Protector's proven Device Control feature will add to this new layer of protection, enabling a further layer of management over devices that have been approved to connect.
"Our DLP and Device Control solutions have become more important than ever before," adds Foeckl. "Enterprises are demanding greater control over the devices that employees connect to their endpoints as a way to combat data loss, and USB threats. Endpoint Protector is the only enterprise DLP solution with Device Control capabilities that achieves this level of granular management within macOS and multi-OS environments."
More on ncarol.com
- Freight Broker 911 CEO and President Milton Collier Is Rebuilding the Path Into Freight Brokerage
- Boston Industrial Solutions Launches New and Improved Siliart Website for Silicone Decorators
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Phoenix
- Sky Quarry's Big Turning Point: CEO Marcus Laun Outlines the Next Phase for N A S D A Q: SKYQ
- ALIPAC Releases List of 170+ Illegal Noncitizen Voter Indicators
About CoSoSys
Built to protect organizations from insider threats, accidental loss, and data compliance breaches, Endpoint Protector combines the visibility needed to identify at-risk data on the endpoint with the controls to stop data loss in its tracks. With support for macOS, Windows, and Linux, Endpoint Protector is proven in the enterprise and trusted across regulated industries that want to reduce the risk of a data compliance breach, or data loss from malicious, negligent, and compromised users, and demand continuous protection wherever their employees are working, even when they're offline, without impacting productivity.
Contacts
Codina Sabau, Ph.D
codina.sabau@cososys.com
www.endpointprotector.com
Filed Under: Business
0 Comments
Latest on ncarol.com
- Crossroads4Hope Launches Blood Cancer Resource Hub
- NIL Club Data Shows Brands Are Looking Beyond Follower Counts in College Sports
- Georgia's Magical Nights of Lights Bigger and Brighter for 2026
- Men Moving Mountains Expands Full-Service Moving Options in Boone, NC and the High Country
- Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
- NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
- OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
- Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
- "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
- Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
- Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"
- 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
- Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
- Advantage Newspaper Consultants Celebrates 30 Years of Serving the Newspaper Industry
- Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
- [New Book] "Historic Maps of Charlotte" Available Now!
- Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
- HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
- AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
- $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc